Medicis Pharmaceutial Newswire (Page 2)

Medicis Pharmaceutial Newswire (Page 2)

Comprehensive Real-Time News Feed for Medicis Pharmaceutial. (Page 2)

Results 21 - 24 of 24 in Medicis Pharmaceutial

  1. Medicis Pharmaceutical Corp (MRX) versus Depomed (DEPO) Critical SurveyRead the original story w/Photo

    Nov 23, 2017 | AmericanBankingNews.com

    Medicis Pharmaceutical Corp and Depomed are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, institutional ownership, earnings, profitability and dividends. This is a summary of current recommendations and price targets for Medicis Pharmaceutical Corp and Depomed, as reported by MarketBeat.

    Comment?

  2. Medicis Pharmaceutical Corp (MRX) and Depomed (DEPO) Financial SurveyRead the original story w/Photo

    Nov 13, 2017 | The Breeze

    Medicis Pharmaceutical Corp and Depomed are both generic pharmaceuticals companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk. 87.4% of Depomed shares are owned by institutional investors.

    Comment?

  3. Send Press Releases with GlobeNewswireRead the original story

    Oct 3, 2017 | GlobeNewswire

    Fixed income: Listing of a bond loan issued by J.P. Morgan International Derivatives Ltd. on OMX Nordic Exchange Stockholm's Retail Bonds List

    Comment?

  4. Dermavant Sciences Appoints Vince Ippolito As President And Chief Operating OfficerRead the original story

    Sep 28, 2017 | BioSpace

    "Vince brings a tremendous wealth of experience in dermatology. His track record speaks for itself and he has generated significant value for shareholders over the course of his highly successful career."

    Comment?